首页> 外文期刊>European journal of clinical pharmacology >Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population.
【24h】

Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population.

机译:芬兰成年人口每天使用非处方药的频率以及潜在的具有临床意义的非处方药相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To explore the frequency of continuous use of over-the-counter (OTC) drugs among the Finnish adult population and the potential for harmful interactions between OTC drugs and prescribed (Rx) drugs. METHODS: Data were extracted from a 1995-1996 population-based interview survey on health care (n = 10,477, response rate 86%). The drug interaction classification system from the Swedish Drug Compendium FASS 1997 was used to identify OTC drugs likely to have clinically significant interactions with prescription drugs. Logistic regression was used to study factors related to continuous use and risks for interactions. RESULTS: Seventeen percent of the population had used OTC drugs and 15% had used OTC vitamins during the 2 days prior to the interview. Daily use of OTC drugs and of vitamins was reported by 7% and 9%, respectively. Continuous use of OTC drugs was related to older age, female gender, higher education, poor health status, long-term morbidity, psychosomatic symptoms (fatigue) and use of prescription drugs, but not to poor lifestyle. Four percent of the OTC drug users had taken drug combinations with potential for clinically significant interactions. Interactions were most common for ketoprofen (15% of ketoprofen users), ibuprofen (10%), and acetylsalicylic acid (ASA) (6%). The number of prescription drugs, long-term illness and lower education best explained the risk for interactions. CONCLUSION: Continuous use and potentially harmful Rx/ OTC drug interactions occur among OTC drug users. Further studies should be done to investigate whether potential combinations will actually lead to clinical problems. The possible interactions of non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics with prescription drugs should especially be taken into account in drug information.
机译:目的:探讨芬兰成年人口中连续使用非处方药(OTC)的频率以及非处方药与处方药(Rx)之间有害相互作用的可能性。方法:数据摘自1995-1996年基于人群的医疗保健访问调查(n = 10477,响应率86%)。瑞典药物简报FASS 1997的药物相互作用分类系统用于鉴定可能与处方药具有临床显着相互作用的OTC药物。 Logistic回归用于研究与持续使用和相互作用风险相关的因素。结果:在访谈前的两天内,有17%的人口使用了OTC药物,而15%的人使用了OTC维生素。据报告,每天使用非处方药和维生素的比例分别为7%和9%。继续使用OTC药物与年龄,女性,高等教育,健康状况差,长期发病率,心身症状(疲劳)和处方药的使用有关,但与不良的生活方式无关。 OTC吸毒者中有4%服用了可能具有临床上显着相互作用的药物组合。交互作用对酮洛芬(占酮洛芬使用者的15%),布洛芬(占10%)和乙酰水杨酸(ASA)(占6%)最为常见。处方药的数量,长期疾病和较低的教育程度可以最好地解释这种相互作用的风险。结论:OTC吸毒者之间持续使用Rx / OTC药物并可能产生有害相互作用。应该做进一步的研究以调查潜在的组合是否会真正导致临床问题。非甾体类抗炎药(NSAID)和止痛药与处方药之间可能的相互作用应在药物信息中特别考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号